 Home > Biochemistry News > Biotechnology News > Reco Bio announced pre-clinical research data: ReCOV vaccine has good cross-immunity activity against a variety of mutant strains

Reco Bio announced pre-clinical research data: ReCOV vaccine has good cross-immunity activity against a variety of mutant strains

 Last Update: 2021-12-03
 Source: Internet
 Author: User

Tags

types viral infection

future health

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Taizhou, Jiangsu, November 9, 2021/PRNewswire/ - Jiangsu Ruike Biotechnology Co.

Dr.

This study used a variety of methods and showed that after two doses of ReCOV vaccine, high levels of neutralizing antibodies are produced.

In the CAG-hACE2 transgenic mouse model, ReCOV can protect mice against the lethal infection of SARS-CoV-2 virus.

More importantly, ReCOV can induce the body to produce powerful neutralizing antibodies and protect rhesus monkeys from the new coronavirus infection

These results support the further clinical development of ReCOV, which is currently being evaluated in a phase I clinical trial in New Zealand (NCT04818801)

About the recombinant two-component new coronary pneumonia vaccine ReCOV

In May 2020, Reco Bio, together with the Jiangsu Provincial Center for Disease Control and Prevention, and the Taizhou Medical Park Administrative Committee, jointly developed a recombinant two-component new coronary pneumonia vaccine (CHO cell) (hereinafter referred to as ReCOV vaccine)

About Ruike Bio

Ruike Biotechnology is an innovative vaccine company founded in 2012.

The information published in this press release may contain certain forward-looking statements

These forward-looking statements are based on the current views, assumptions, expectations, estimates, forecasts and understandings of the company’s management on future affairs at the time the statement is made

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.